Ignorer Navigation principale
Contenu de page

Sauvegarder cet événement

Événement sauvegardé

DeepTechWeek - Institut Curie - From discovery to gold standard in Oncology

Institut Curie

Lundi 9 mars 2020 de 13:30 à 21:00 (heure : France)

DeepTechWeek - Institut Curie - From discovery to gold...

Informations sur les billets

Type Fin Quantité
Billet 1j 23h 39m Gratuit  

Partagez DeepTechWeek - Institut Curie - From discovery to gold standard in Oncology

Description de l'événement

From discovery to gold standard in Oncology

The identification of these breakthrough innovations at the earliest stage is the grail of most stakeholders at the interface of research and development. The goal of this workshop is to share practice from France and abroad ensuring that the next big thing would be properly identified, protected, maturated and transferred from academia to the industry ensuring a successful development that would reach researchers and patients at some point.

Researchers, clinicians and industries have witnessed the emergence of broad range of innovations over the past years in Oncology, including but not limited to cell and gene therapies, machine learning and immunotherapy.
Being able to forecast the next one is a tricky game of changing targets, as drug candidates or methods might be already under development within labs.

Therefore, this conference aims to:
  • Raise the awareness of all the stakeholders involved in the improvements of cancer diagnosis and therapies.
  • Have experts from multiple domains including both scientific and business perspective sharing their experience and their opinions on the future of oncology.
  • Promote discussion on the future of therapies and networking among the participants.

13h30 Introduction

  • Sarah Pedroza, Co-managing Director - Hello Tomorrow
  • Amaury Martin, Head of tech transfer office - Institut Curie

The place of Tech transfer in France and abroad - hosted by Isabelle Peltier-Bressac, Founder & CEO at AttLeva Conseils

  • Amaury Martin, Head of tech transfer office - Institut Curie
  • Cédric Denis-Remi, Vice President Innovation PSL
  • Eliane Piaggo, Research Team Leader in Translational Immunology - Institut Curie
  • Stephanie Marrus, Director of the Entrepreneurship Center - University of California, San Francisco

Tech transfer option: entrepreneurship or license - hosted by Bruno Rostand, Innovation & Entrepreneurship Director - PSL

  • Jérémie Weber, Start-up, licence and industrial parternships Manager - Institut Curie
  • Luc Boblet, Serial entrepreneur
  • Frederic Scaerou, Lead Director, Business Development & Licensing, Oncology at Servier Pharmaceuticals

Coffee Break

From discovery to early stage clinical trial - hosted by Amaury Martin Head of tech transfer office - Institut Curie

  • Arnaud Foussat Partner – Advent Life Sciences, CEO Alderaan biotechnology, CEO Yukin Therapeutics
  • Marisol Urbieta, Oncology Medical Affairs Head – Astrazeneca
  • Manuel Rodriguez, Oncologist at Institut Curie

From innovation to gold standard - hosted by Timothé Cynober, Business Manager - Institut Curie

  • Decebal Bora, VP Regulatory Science - Voisin Consulting Life science
  • Jean Marc PINGUET, National Market Access and Pricing Director, Personalized Healthcare Director - Roche France
  • Sylvie Bonvalot, Visceral and digestive Surgeon - Institut Curie
  • To be confirmed

Conclusion - Amaury Martin

Cocktail & Networking

For more information, contact the organizer: timothe.cynober@curie.fr
Des questions sur l'événement DeepTechWeek - Institut Curie - From discovery to gold standard in Oncology ? Contactez Institut Curie

Sauvegarder cet événement

Événement sauvegardé

Où et quand


Amphitéatre Burg
12, rue Lhomond
75005 Paris
France

Lundi 9 mars 2020 de 13:30 à 21:00 (heure : France)


  Ajouter à mon calendrier

Organisateur

Institut Curie

Institut Curie is one of the largest European Comprehensive Cancer Centers (CLCC) and member of UNICANCER with a strong and old interdisciplinary tradition. It comprises a research center (~1100 persons) and two cancer hospitals (~2200 persons). Institut Curie has a continuum of expertise ranging from fundamental research on biology of cancer cells to translational research, clinical research, patient care and data science. Institut Curie encompasses many assets and skills that provide a unique environment to develop the innovative care and treatment to defeat cancer, and make the best use of cutting-edge informatics technologies to achieve this goal.

For more information : www.curie.fr

Institut Curie is part of Institut Carnot: Founded in 2006, the Carnot Label was designed to develop partnership-based research, meaning research conducted by public laboratories in partnership with socio-economic players, primarily industry (from SMEs to large corporations), to serve their needs. The Carnot Label is granted to public research structures, Carnot institutes, with proven, high level R&I competencies dedicated to fostering innovation with industrial partners. They concurrently conduct upstream research capable of renewing their scientific and technological skills, and an ambitious partnership research policy to the benefit of the socio-economic world.

https://findmed.fr/wp-content/uploads/2018/05/LOGO_Findmed_bloc-4.jpg

  Contacter l'organisateur

Vous avez envie d'organiser votre propre événement ?

Rejoignez des millions d'autres personnes sur Eventbrite.

Connectez-vous ou ouvrez un compte

Pour acheter ces billets en plusieurs versements, vous devez disposer d'un compte Eventbrite. Connectez-vous ou ouvrez un compte gratuitement pour continuer.